Hudbay Minerals Inc. (HBM)vsVertex Pharmaceuticals Inc (VRTX)
HBM
Hudbay Minerals Inc.
$25.02
+4.91%
BASIC MATERIALS · Cap: $9.47B
VRTX
Vertex Pharmaceuticals Inc
$429.82
+1.13%
HEALTHCARE · Cap: $107.87B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 415% more annual revenue ($12.22B vs $2.37B). VRTX leads profitability with a 35.5% profit margin vs 27.8%. HBM appears more attractively valued with a PEG of 2.09. HBM earns a higher WallStSmart Score of 77/100 (B+).
HBM
Strong Buy77
out of 100
Grade: B+
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-71.4%
Fair Value
$15.42
Current Price
$25.02
$9.60 premium
Margin of Safety
+57.2%
Fair Value
$992.87
Current Price
$429.82
$563.05 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Strong operational efficiency at 40.0%
Earnings expanding 91.9% YoY
Keeps 28 of every $100 in revenue as profit
Attractively priced relative to earnings
Revenue surging 27.3% year-over-year
Keeps 36 of every $100 in revenue as profit
Strong operational efficiency at 38.1%
Earnings expanding 61.4% YoY
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 24 in profit
Areas to Watch
Expensive relative to growth rate
Weak financial health signals
Distress zone — elevated risk
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : HBM
The strongest argument for HBM centers on Operating Margin, EPS Growth, Profit Margin. Profitability is solid with margins at 27.8% and operating margin at 40.0%. Revenue growth of 27.3% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, EPS Growth. Profitability is solid with margins at 35.5% and operating margin at 38.1%.
Bear Case : HBM
The primary concerns for HBM are PEG Ratio, Piotroski F-Score, Altman Z-Score.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
HBM profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
HBM carries more volatility with a beta of 2.15 — expect wider price swings.
HBM is growing revenue faster at 27.3% — sustainability is the question.
VRTX generates stronger free cash flow (1.3B), providing more financial flexibility.
Bottom Line
HBM scores higher overall (77/100 vs 66/100), backed by strong 27.8% margins and 27.3% revenue growth. VRTX offers better value entry with a 57.2% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Hudbay Minerals Inc.
BASIC MATERIALS · COPPER · USA
Hudbay Minerals Inc., a diversified mining company, focuses on the discovery, production and marketing of base and precious metals in North and South America. The company is headquartered in Toronto, Canada.
Visit Website →Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other COPPER Stocks
Want to dig deeper into these stocks?